| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |